80 related articles for article (PubMed ID: 25065294)
1. Differential risks of cancer types in people with Parkinson's disease: a national record-linkage study.
Ong EL; Goldacre R; Goldacre M
Eur J Cancer; 2014 Sep; 50(14):2456-62. PubMed ID: 25065294
[TBL] [Abstract][Full Text] [Related]
2. Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study.
Seminog OO; Ogunlaja OI; Yeates D; Goldacre MJ
J R Soc Med; 2016 Aug; 109(8):303-9. PubMed ID: 27325377
[TBL] [Abstract][Full Text] [Related]
3. Risk of Parkinson's disease-related death in cancer survivors: A population-based study in Japan.
Hayano E; Gon Y; Kimura Y; Zha L; Morishima T; Ohno Y; Mochizuki H; Sobue T; Miyashiro I
Parkinsonism Relat Disord; 2024 Feb; 119():105966. PubMed ID: 38147694
[TBL] [Abstract][Full Text] [Related]
4. Association between Parkinson's Disease and Cancer: New Findings and Possible Mediators.
Surguchov A; Surguchev AA
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612708
[TBL] [Abstract][Full Text] [Related]
5. A Response to the Paal et al. Rejoinder: Religiosity and Risk of Parkinson's Disease in England and the USA.
Koenig HG
J Relig Health; 2023 Dec; 62(6):4215-4221. PubMed ID: 36607566
[TBL] [Abstract][Full Text] [Related]
6. Frequency and profile of Parkinson's disease prodromi in patients with malignant melanoma.
Walter U; Heilmann E; Voss J; Riedel K; Zhivov A; Schäd SG; Gross GE; Benecke R; Trcka J
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):302-10. PubMed ID: 25817520
[TBL] [Abstract][Full Text] [Related]
7. Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease.
Ritz B; Lee PC; Lassen CF; Arah OA
Neurology; 2014 Oct; 83(16):1396-402. PubMed ID: 25217056
[TBL] [Abstract][Full Text] [Related]
8. Association Between Parkinson Disease and Risk of Cancer in Taiwan.
Lin PY; Chang SN; Hsiao TH; Huang BT; Lin CH; Yang PC
JAMA Oncol; 2015 Aug; 1(5):633-40. PubMed ID: 26181771
[TBL] [Abstract][Full Text] [Related]
9. A recurrent mutation in PARK2 is associated with familial lung cancer.
Xiong D; Wang Y; Kupert E; Simpson C; Pinney SM; Gaba CR; Mandal D; Schwartz AG; Yang P; de Andrade M; Pikielny C; Byun J; Li Y; Stambolian D; Spitz MR; Liu Y; Amos CI; Bailey-Wilson JE; Anderson M; You M
Am J Hum Genet; 2015 Feb; 96(2):301-8. PubMed ID: 25640678
[TBL] [Abstract][Full Text] [Related]
10. The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.
Tell-Marti G; Puig-Butille JA; Potrony M; Badenas C; Milà M; Malvehy J; Martí MJ; Ezquerra M; Fernández-Santiago R; Puig S
Ann Neurol; 2015 May; 77(5):889-94. PubMed ID: 25631192
[TBL] [Abstract][Full Text] [Related]
11. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction.
Wu CR; Tsai CW; Chang SW; Lin CY; Huang LC; Tsai CW
Chem Biol Interact; 2015 Jan; 225():40-6. PubMed ID: 25446857
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk in patients with Parkinson's disease in South Korea: A nationwide, population-based cohort study.
Park JH; Kim DH; Park YG; Kwon DY; Choi M; Jung JH; Han K
Eur J Cancer; 2019 Aug; 117():5-13. PubMed ID: 31229950
[TBL] [Abstract][Full Text] [Related]
13. Cancer in Parkinson's disease.
Tacik P; Curry S; Fujioka S; Strongosky A; Uitti RJ; van Gerpen JA; Diehl NN; Heckman MG; Wszolek ZK
Parkinsonism Relat Disord; 2016 Oct; 31():28-33. PubMed ID: 27372241
[TBL] [Abstract][Full Text] [Related]
14. Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study.
Peretz C; Gurel R; Rozani V; Gurevich T; El-Ad B; Tsamir J; Giladi N
Parkinsonism Relat Disord; 2016 Jul; 28():68-72. PubMed ID: 27161827
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma.
Arnold MR; Cohn GM; Oxe KC; Elliott SN; Moore C; Laraia PV; Shekoohi S; Brownell D; Meshul CK; Witt SN; Larsen DH; Unni VK
bioRxiv; 2024 Jan; ():. PubMed ID: 38260370
[TBL] [Abstract][Full Text] [Related]
16. Absence of causal relationship between Parkinson's disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies.
Wang L; Deng JY; Fan XY; Yang D; Zhu PY; Wang XM
Front Oncol; 2023; 13():1323812. PubMed ID: 38239652
[TBL] [Abstract][Full Text] [Related]
17. 2-Methoxyestradiol and Hydrogen Peroxide as Promising Biomarkers in Parkinson's Disease.
Bastian P; Konieczna L; Dulski J; Daca A; Jacewicz D; Płoska A; Knap N; Sławek J; Bączek T; Kalinowski L; Drzeżdżon J; Roszmann A; Belka M; Górska-Ponikowska M
Mol Neurobiol; 2024 Jan; 61(1):148-166. PubMed ID: 37589832
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal study of the inverse relationship between Parkinson's disease and cancer in Korea.
Kim SY; Choi HG; Kim YH; Kwon MJ; Kim JH; Lee HS; Kim JH
NPJ Parkinsons Dis; 2023 Jul; 9(1):116. PubMed ID: 37481603
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous malignancies in patients with Parkinson's disease at a dermato-oncological university centre in Hungary.
Tóth V; Diakoumakou SC; Kuroli E; Tóth B; Kuzmanovszki D; Szakonyi J; Lőrincz KK; Somlai B; Kárpáti S; Holló P
Front Oncol; 2023; 13():1142170. PubMed ID: 37274278
[TBL] [Abstract][Full Text] [Related]
20. Understanding the role of dopamine in cancer: past, present and future.
Grant CE; Flis AL; Ryan BM
Carcinogenesis; 2022 Jun; 43(6):517-527. PubMed ID: 35616105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
